JBC, Vol. 250, Issue 23, 8990-8996, Dec, 1975

The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor

K. Megyesi, C. R. Kahn, J. Roth, D. M. Neville Jr, S. P. Nissley, R. E. Humbel and E. R. Froesch

NSILA-s (nonsuppressible insulin-like activity, soluble in acid ethanol) is a serum peptide that has insulin-like and growth-promoting activities. We have demonstrated previously that liver plasma membranes possess separate receptors for NSILA-s and insulin and have characterized the insulin receptor in detail. In the present study we have characterized the properties and specificity of the NSILA-s receptor and compared them to those of the insulin receptor in the same tissue. Both 125I-NSILA-s and 125I-insulin bind rapidly and reversibly to their receptors in liver membranes; maximal NSILA-s binding occurs at 20 degrees while maximal insulin binding is seen at 1-4 degrees. The pH optimum for NSILA-s binding is broad (6.0 to 8.0), in contrast to the very sharp pH optimum (7.5 to 8.0) for insulin binding. Both receptors exhibit a high degree of specificity. With the insulin receptor, NSILA-s and insulin analogues compete for binding in proportion to their insulin-like potency: insulin greater than proinsulin greater than NSILA-s. With the NSILA-s receptor, NSILA-s is most potent and the order is reversed: NSILA-s greater than proinsulin greater than insulin. Furthermore, six preparations of NSILA-s which varied 70-fold in biological activity competed for 125I-NSILA-s binding in order of their potencies. NSILA-s which had been inactivated biologically by reduction and aminoethylation and growth hormone were less than 1/100,000 as potent as the most purified NSILA-s preparation. Purified preparations of fibroblast growth factor, epidermal growth factor, nerve growth factor, and somatomedins B and C were less than 1% as effective as NSILA-s in competing for the 125I-NSILA-s suggesting that these factors act through other receptors. In contrast, somatomedin A was 10% as active as NSILA-s and multiplication-stimulating activity was fully as active as NSILA-s in competing for the NSILA-s receptor. Analysis of the data suggests that there are approximately 50 times more insulin receptors than NSILA-s receptors per liver cell, while the apparent affinity of NSILA-s receptors is somewhat higher than that of the insulin receptor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C W Ward, T P J Garrett, N M McKern, M Lou, L J Cosgrove, L G Sparrow, M J Frenkel, P A Hoyne, T C Elleman, T E Adams, et al. The three dimensional structure of the type I insulin-like growth factor receptor Mol. Pathol., June 1, 2001; 54(3): 125 - 132. [Abstract] [Full Text]

				C. Heldin, A Wasteson, L Fryklund, and B Westermark Somatomedin B: mitogenic activity derived from contaminant epidermal growth factor Science, September 4, 1981; 213(4512): 1122 - 1123. [Abstract] [PDF]